Deciphera Pharmaceuticals Names Michael D. Taylor President and CEO

Deciphera Pharmaceuticals has announced that Michael D. Taylor has been announced as the company’s President and Chief Executive Officer. Additionally, as part of the company’s evolution, Deciphera will open new corporate offices in the Boston area. Prior to joining Deciphera, Taylor was CEO of Ensemble Therapeutics and, prior to Ensemble, he served as Senior Vice President for Pfizer’s Global R&D division and served as Vice-President, Drug Development at Warner-Lambert/Parke-Davis.